glimepiride 2 MG / pioglitazone 30 MG Oral Tablet
glimepiride
RxCUI: 647237
What the CMS Formulary Data Shows for glimepiride 2 MG / pioglitazone 30 MG Oral Tablet
Per the CMS 2026 Part D formulary file, glimepiride 2 MG / pioglitazone 30 MG Oral Tablet (RxNorm concept RXCUI 647237, generic name glimepiride) appears on 80 distinct formulary files spanning 2,411 Medicare Part D plan offerings - 47.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 3.
Real-world access to glimepiride 2 MG / pioglitazone 30 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 85% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,187,344 Part D beneficiaries filled glimepiride 2 MG / pioglitazone 30 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $62,964,614 and an average per-beneficiary annual cost of $53.03. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry glimepiride 2 MG / pioglitazone 30 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 80
- Plans covering
- 2,411
- Coverage rate
- 47.6%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 85% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,187,344
- Total spending
- $62,964,614
- Avg per beneficiary
- $53.03
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering glimepiride 2 MG / pioglitazone 30 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is glimepiride 2 MG / pioglitazone 30 MG Oral Tablet covered by Medicare Part D?
Yes, glimepiride 2 MG / pioglitazone 30 MG Oral Tablet is covered by 2,411 Medicare Part D plans (47.6% of all Part D formularies).
What tier is glimepiride 2 MG / pioglitazone 30 MG Oral Tablet on Medicare Part D plans?
glimepiride 2 MG / pioglitazone 30 MG Oral Tablet averages Tier 3 across Part D plans, ranging from Tier 1 to Tier 6.
Does glimepiride 2 MG / pioglitazone 30 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for glimepiride 2 MG / pioglitazone 30 MG Oral Tablet. Step therapy: 0%. Quantity limits: 85%.
How much does Medicare spend on glimepiride 2 MG / pioglitazone 30 MG Oral Tablet?
In 2023, total Medicare Part D spending on glimepiride 2 MG / pioglitazone 30 MG Oral Tablet was $62,964,614, covering 1,187,344 beneficiaries. The average spend per beneficiary was $53.03.
Read our methodology - how this data is sourced, computed, and verified.